| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,296 | 4,745 | 3,240 | 3,782 | | Cost of Revenue | 102 | 75 | 52 | 40 | | | Gross Profit | 4,194 | 4,670 | 3,188 | 3,742 | | | Operating Expenses | | Research Development | 729 | 690 | 675 | 648 | | Selling General and Administrative | 2,396 | 2,846 | 2,583 | 3,054 | | Non Recurring |
-
|
-
|
-
| 9,017 | | Others | 187 | 178 | 172 | 381 | | | | Total Operating Expenses |
-
|
-
|
-
| 13,099 | | | | Operating Income or Loss | 882 | 956 | (242) | (9,357) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3 | (52) | 10 | 29 | | Earnings Before Interest And Taxes | 885 | 904 | (231) | (9,328) | | Interest Expense |
-
|
-
|
-
| 7 | | Income Before Tax | 885 | 904 | (231) | (9,335) | | Income Tax Expense | 309 | (39) | 13 | (1,004) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 576 | 943 | (244) | (8,331) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 576 | 943 | (244) | (8,331) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $576 | $943 | ($244) | ($8,331) |
|
0.02% Nasdaq 
0.33%
Income Statement
